WA

Waystar Holding Corp.

WAYHealthcareNASDAQ

Health Information Services · Last scanned Sep 9, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$1.10B
+16.5% YoY
Net Income
$112.1M
+686.1% YoY
EBITDA
$389.9M
+25.6% YoY
Free Cash Flow
$313.7M

Scan Results

Daily timeframe
4 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Sep 2 MACD Positive CrossoverHistogram +0.0429, positive momentum
Sep 1 MACD Positive CrossoverHistogram +0.0541, positive momentum
About Waystar Holding Corp.

Waystar Holding Corp. develops a cloud-based software solution for healthcare payments. At a $4.65B market cap, Waystar Holding Corp. ranks as a mid-cap company within healthcare. Its platform offers financial clearance, patient financial care, claim and payer payment management, denials prevention and recovery, clinical integrity and revenue capture, and analytics and reporting solutions.

Where WAY stands vs its 150-day and 200-day moving averages

As of the September 2, 2026 close, WAY finished 12.49% above its 150-day moving average ($22.90) and 1.38% above its 200-day moving average ($25.41). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is WAY overbought or oversold?

At the September 2, 2026 close, WAY's RSI(14) was 60.1, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$4.65B
P/E (TTM)34.63
Fwd P/E12.91
EPS$0.70
Beta0.15
52W Change-38.1%
ROE3.8%
Analysis

Waystar Holding Corp. carries $1.48B in total debt against $193.5M in cash reserves — debt is roughly 7.7x the cash position. Managing this leverage effectively will be important for long-term financial stability. The company generates $313.7M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at 3.8%, which is modest for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 3.4% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $704.9M (2022) to $1.10B (2025), reflecting a 56% increase over the period.

The relatively low beta of 0.15 suggests WAY is a less volatile holding compared to the broader index. Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Waystar Holding Corp.'s trajectory.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms